Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Cecilia Bergonzini

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0789-118X; OpenAlex author ID A5030164875. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 5 papers

Papers 7

  1. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells. Co-author DOI 10.1016/j.ijrobp.2023.10.035↗
  2. Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, … Co-author DOI 10.1080/1061186x.2024.2385557↗
  3. ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells. Co-author DOI 10.1186/s13046-023-02879-8↗
  4. Targeting ABC transporters in PDAC - past, present, or future? Co-author DOI 10.18632/oncotarget.28597↗
  5. Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel. First author DOI 10.3390/cancers16223863↗
  6. Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC). First author DOI 10.3390/cancers15030628↗
  7. Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.1016/j.ejmech.2020.112088↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elisa Giovannetti · 7 shared papers, 2020–2024 · strength 1.42
  2. Erik H.J. Danen · 5 shared papers, 2023–2024 · strength 1.13
  3. Thomas Schmidt · 4 shared papers, 2023–2024 · strength 0.76
  4. Alessandro Gregori · 4 shared papers, 2023–2024 · strength 0.76
  5. Mjriam Capula · 3 shared papers, 2023–2024 · strength 0.58
  6. Liam Andrew McDonnell · 2 shared papers, 2024 · strength 0.36
  7. Daniela Carbone · 2 shared papers, 2020–2024 · strength 0.29
  8. Stella Cascioferro · 2 shared papers, 2020–2024 · strength 0.29
  9. Barbara Parrino · 2 shared papers, 2020–2024 · strength 0.29
  10. Patrizia Diana · 2 shared papers, 2020–2024 · strength 0.29
  11. Fabio Scianò · 1 shared paper, 2024 · strength 0.20
  12. Geng Xu · 1 shared paper, 2024 · strength 0.20
  13. Camilla Pecoraro · 1 shared paper, 2024 · strength 0.20
  14. Pei Pei · 1 shared paper, 2024 · strength 0.18
  15. Adam Enver Frampton · 1 shared paper, 2024 · strength 0.18
  16. Asia Botto · 1 shared paper, 2024 · strength 0.18
  17. Ingrid Garajová · 1 shared paper, 2024 · strength 0.18
  18. Annalisa Comandatore · 1 shared paper, 2023 · strength 0.16
  19. Fatemeh Khojasteh‐Leylakoohi · 1 shared paper, 2023 · strength 0.16
  20. Luca Morelli · 1 shared paper, 2023 · strength 0.16
  21. Amir Avan · 1 shared paper, 2023 · strength 0.16
  22. Giovanna Li Petri · 1 shared paper, 2020 · strength 0.10
  23. Niccola Funel · 1 shared paper, 2020 · strength 0.10
  24. Godefridus J. Peters · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.